SLC41A3 and adrenal cortex carcinoma: The results revealed that increased SLC41A3 expression predicted better prognosis in ACC, DLBC, KIRP, KIRC, PCPG, THYM, and UVM, nevertheless, patients with low SLC41A3 expression showed remarkably good clinical outcome (OS) in LIHC and OV (Figures 3A–I).